Published in Cell on December 27, 1996
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol (2009) 5.55
Blood vessel formation: what is its molecular basis? Cell (1996) 5.54
Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol (2001) 5.17
The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol (2005) 4.54
Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med (2008) 3.98
The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev (1999) 3.14
A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases. Mol Cell (2007) 2.70
A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest (1999) 2.64
The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease. Philos Trans R Soc Lond B Biol Sci (1998) 2.53
Microvascular patterning is controlled by fine-tuning the Akt signal. Proc Natl Acad Sci U S A (2004) 2.39
Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci U S A (2000) 2.23
Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev (1998) 2.16
Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest (2011) 2.09
Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet (2008) 1.95
Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci U S A (1999) 1.84
Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance. Science (2014) 1.77
Venous malformation: update on aetiopathogenesis, diagnosis and management. Phlebology (2010) 1.73
Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ("glomangiomas"). Am J Hum Genet (2002) 1.66
Cerebral cavernous malformation: new molecular and clinical insights. J Med Genet (2006) 1.52
Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway. Br J Haematol (2006) 1.51
Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest (1999) 1.42
In silico cloning of novel endothelial-specific genes. Genome Res (2000) 1.42
Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. Am J Pathol (2001) 1.40
Biomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis. Cell Mol Life Sci (2005) 1.37
A gene for inherited cutaneous venous anomalies ("glomangiomas") localizes to chromosome 1p21-22. Am J Hum Genet (1999) 1.37
A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo. Blood (2009) 1.37
VE-PTP controls blood vessel development by balancing Tie-2 activity. J Cell Biol (2009) 1.32
Genetic considerations relevant to intracranial hemorrhage and brain arteriovenous malformations. Acta Neurochir Suppl (2008) 1.28
The extracellular matrix and blood vessel formation: not just a scaffold. J Cell Mol Med (2007) 1.25
Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis. Br J Cancer (1998) 1.25
Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology. Proc Natl Acad Sci U S A (2011) 1.23
From germline towards somatic mutations in the pathophysiology of vascular anomalies. Hum Mol Genet (2009) 1.23
Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. Am J Pathol (2000) 1.22
Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur J Hum Genet (2009) 1.17
Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway. Proc Natl Acad Sci U S A (2003) 1.17
Bmx tyrosine kinase has a redundant function downstream of angiopoietin and vascular endothelial growth factor receptors in arterial endothelium. Mol Cell Biol (2001) 1.15
Elevated expression of c-kit in small venous malformations of blue rubber bleb nevus syndrome. Rare Tumors (2010) 1.13
Endogenous endothelial cell signaling systems maintain vascular stability. Angiogenesis (2009) 1.12
TIE2 gain-of-function mutation in a patient with pancreatic lymphangioma associated with blue rubber-bleb nevus syndrome: report of a case. Surg Today (2006) 1.12
Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment. Blood (2006) 1.11
Growth inhibition by keratinocyte growth factor receptor of human salivary adenocarcinoma cells through induction of differentiation and apoptosis. Proc Natl Acad Sci U S A (2001) 1.10
Hyperglycemia-induced vasculopathy in the murine vitelline vasculature: correlation with PECAM-1/CD31 tyrosine phosphorylation state. Am J Pathol (1999) 1.09
Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? Am J Pathol (1998) 1.07
Angiogenesis and vascular malformations: antiangiogenic drugs for treatment of gastrointestinal bleeding. World J Gastroenterol (2007) 1.06
The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway. Cold Spring Harb Perspect Med (2012) 1.06
Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity. J Clin Invest (2016) 1.05
A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice. Am J Pathol (2005) 1.04
Receptor tyrosine kinase-mediated angiogenesis. Cold Spring Harb Perspect Biol (2013) 1.01
Signaling mechanisms in infantile hemangioma. Curr Opin Hematol (2009) 1.00
Embryonic stem cell tumor model reveals role of vascular endothelial receptor tyrosine phosphatase in regulating Tie2 pathway in tumor angiogenesis. Proc Natl Acad Sci U S A (2009) 1.00
Natural antisense transcript: a concomitant engagement with protein-coding transcript. Oncotarget (2010) 0.99
Pathogenesis of hemangioma. J Clin Invest (2001) 0.99
A lymphatic defect causes ocular hypertension and glaucoma in mice. J Clin Invest (2014) 0.98
The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice. J Exp Med (2009) 0.98
p53 functions in endothelial cells to prevent radiation-induced myocardial injury in mice. Sci Signal (2012) 0.98
Somatic Activating PIK3CA Mutations Cause Venous Malformation. Am J Hum Genet (2015) 0.98
Pathogenesis of vascular anomalies. Clin Plast Surg (2011) 0.93
Zebrafish Tie-2 shares a redundant role with Tie-1 in heart development and regulates vessel integrity. Dis Model Mech (2010) 0.92
Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB. Hum Mol Genet (2013) 0.91
Brain pericytes: emerging concepts and functional roles in brain homeostasis. Cell Mol Neurobiol (2011) 0.91
Signaling required for blood vessel maintenance: molecular basis and pathological manifestations. Int J Vasc Med (2011) 0.91
Vascular anomalies: from genetics toward models for therapeutic trials. Cold Spring Harb Perspect Med (2012) 0.91
Nd:YAG lasers (1,064 nm) in the treatment of venous malformations of the face and neck: challenges and benefits. Lasers Med Sci (2007) 0.91
Variable Somatic TIE2 Mutations in Half of Sporadic Venous Malformations. Mol Syndromol (2013) 0.91
Exercise training and peripheral arterial disease. Compr Physiol (2012) 0.90
Identification of a novel marker for primordial smooth muscle and its differential expression pattern in contractile vs noncontractile cells. J Cell Biol (1997) 0.88
Angiopoietin/Tie2 signaling transforms capillaries into venules primed for leukocyte trafficking in airway inflammation. Am J Pathol (2010) 0.88
Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects. J Clin Invest (2015) 0.87
Complex vascular anomalies. Pediatr Surg Int (2013) 0.87
Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma. Am J Hum Genet (2016) 0.87
Pericytes from infantile hemangioma display proangiogenic properties and dysregulated angiopoietin-1. Arterioscler Thromb Vasc Biol (2013) 0.87
Somatic PIK3CA mutations as a driver of sporadic venous malformations. Sci Transl Med (2016) 0.86
Retinoic acid mediates regulation of network formation by COUP-TFII and VE-cadherin expression by TGFbeta receptor kinase in breast cancer cells. PLoS One (2010) 0.85
A somatic MAP3K3 mutation is associated with verrucous venous malformation. Am J Hum Genet (2015) 0.85
Radio-opaque ethylcellulose-ethanol is a safe and efficient sclerosing agent for venous malformations. Eur Radiol (2011) 0.84
Microcephaly, intellectual impairment, bilateral vesicoureteral reflux, distichiasis, and glomuvenous malformations associated with a 16q24.3 contiguous gene deletion and a Glomulin mutation. Am J Med Genet A (2012) 0.83
Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization. Oncotarget (2015) 0.83
Synchronous multiple small bowel intussusceptions in an adult with blue rubber bleb naevus syndrome: Report of a case and review of literature. World J Emerg Surg (2008) 0.83
Complications of sclerotherapy for 75 head and neck venous malformations. Eur Arch Otorhinolaryngol (2015) 0.83
Developmental ablation of Id1 and Id3 genes in the vasculature leads to postnatal cardiac phenotypes. Dev Biol (2010) 0.83
Genomic structure of the human KDR/flk-1 gene. Mamm Genome (1998) 0.82
Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation. J Clin Invest (2016) 0.82
The molecular basis of vascular disorders. Am J Hum Genet (1999) 0.81
Common and specific effects of TIE2 mutations causing venous malformations. Hum Mol Genet (2015) 0.80
Heredity of port-wine stains: investigation of families without a RASA1 mutation. J Cosmet Laser Ther (2015) 0.79
Ligand-independent Tie2 dimers mediate kinase activity stimulated by high dose angiopoietin-1. J Biol Chem (2013) 0.79
Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions. Oncotarget (2015) 0.78
R3 receptor tyrosine phosphatases: conserved regulators of receptor tyrosine kinase signaling and tubular organ development. Semin Cell Dev Biol (2014) 0.78
Lack of TEK Gene Mutation in Patients with Cutaneomucosal Venous Malformations from the North-Western Region of Algeria. Genet Res Int (2013) 0.77
KinMutBase, a database of human disease-causing protein kinase mutations. Nucleic Acids Res (2000) 0.77
A new role of lipid receptors in vascular and cardiac morphogenesis. J Clin Invest (2000) 0.77
Disorganized vascular structures in sporadic venous malformations: a possible correlation with balancing effect between Tie2 and TGF-β. Sci Rep (2014) 0.77
Mechanisms of vascular stability and the relationship to human disease. Curr Opin Hematol (2010) 0.76
Tubular Overexpression of Angiopoietin-1 Attenuates Renal Fibrosis. PLoS One (2016) 0.76
[Skeletal vascular lesions in childhood and adolescence]. Pathologe (2004) 0.75
Insights into endothelial mechanisms through the lens of vascular anomalies. Matrix Biol (2009) 0.75
Vasculogenesis and angiogenesis: molecular and cellular controls. Part 1: growth factors. Interv Neuroradiol (2004) 0.75
From blue jeans to blue genes. J Craniofac Surg (2009) 0.75
Detrimental influences of intraluminally-administered sclerotic agents on surrounding tissues and peripheral nerves: an experimental study. J Plast Surg Hand Surg (2012) 0.75
Expression of the Components of the Renin-Angiotensin System in Venous Malformation. Front Surg (2016) 0.75
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell (1997) 13.94
Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell (1997) 13.53
Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg (1982) 12.85
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
The structural basis for 14-3-3:phosphopeptide binding specificity. Cell (1997) 10.87
PI3K pathway alterations in cancer: variations on a theme. Oncogene (2008) 9.94
Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science (1990) 8.91
Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science (1997) 8.81
Phosphoinositide kinases. Annu Rev Biochem (1998) 8.51
Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science (1997) 8.16
PI3K: downstream AKTion blocks apoptosis. Cell (1997) 7.73
Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell (1997) 7.47
Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature (1997) 7.20
Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques (2000) 7.03
Hereditary hemorrhagic telangiectasia. N Engl J Med (1995) 6.91
A motif-based profile scanning approach for genome-wide prediction of signaling pathways. Nat Biotechnol (2001) 6.50
PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell (1989) 6.26
Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature (1995) 6.16
Use of an oriented peptide library to determine the optimal substrates of protein kinases. Curr Biol (1994) 6.04
Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science (1997) 5.40
Vanadate is a potent (Na,K)-ATPase inhibitor found in ATP derived from muscle. J Biol Chem (1977) 5.16
Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet (1996) 5.15
Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science (1996) 5.13
Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science (1999) 4.77
Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med (1992) 4.76
Purification and characterization of phosphoinositide 3-kinase from rat liver. J Biol Chem (1990) 4.75
The PX domains of p47phox and p40phox bind to lipid products of PI(3)K. Nat Cell Biol (2001) 4.64
The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem (1999) 4.62
A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol Cell Biol (1996) 4.61
TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J (2000) 4.55
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Proc Natl Acad Sci U S A (1994) 4.51
ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol Cell Biol (1994) 4.49
Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell (1995) 4.32
Activation of phosphatidylinositol 3-kinase by insulin. Proc Natl Acad Sci U S A (1990) 4.32
Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science (1999) 4.20
Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding. Mol Cell (1999) 4.02
Determination of the specific substrate sequence motifs of protein kinase C isozymes. J Biol Chem (1997) 3.86
Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol. Proc Natl Acad Sci U S A (1984) 3.84
Two improved methods for preparing ferritin-protein conjugates for electron microscopy. J Cell Biol (1975) 3.81
Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science (1997) 3.73
A characterization of vanadate interactions with the (Na,K)-ATPase. Mechanistic and regulatory implications. J Biol Chem (1978) 3.67
Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. J Biol Chem (2000) 3.66
The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J (2000) 3.64
Distinct roles of class I and class III phosphatidylinositol 3-kinases in phagosome formation and maturation. J Cell Biol (2001) 3.63
A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. Cell (1995) 3.59
Rho family GTPases bind to phosphoinositide kinases. J Biol Chem (1995) 3.49
Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem (1994) 3.46
Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg (1998) 3.42
A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate. Nature (1997) 3.29
Phosphatidylinositol 3-kinase. Bioessays (1994) 3.27
A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J Biol Chem (1997) 3.19
Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet (1999) 3.15
Phosphoinositide 3-kinase is activated by phosphopeptides that bind to the SH2 domains of the 85-kDa subunit. J Biol Chem (1993) 3.14
Somatic mutations in the neurofibromatosis 1 gene in gliomas and primitive neuroectodermal tumours. Anticancer Res (1996) 3.12
Activation of protein kinase C family members by the novel polyphosphoinositides PtdIns-3,4-P2 and PtdIns-3,4,5-P3. J Biol Chem (1994) 3.08
Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation. Am J Med Genet (1999) 3.02
Phosphoinositide kinases. Curr Opin Cell Biol (1996) 3.01
Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg (1999) 2.99
Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest (1994) 2.97
Determination of protease cleavage site motifs using mixture-based oriented peptide libraries. Nat Biotechnol (2001) 2.93
Corequirement of specific phosphoinositides and small GTP-binding protein Cdc42 in inducing actin assembly in Xenopus egg extracts. J Cell Biol (1998) 2.90
In vivo near-infrared fluorescence imaging of osteoblastic activity. Nat Biotechnol (2001) 2.89
A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell (1993) 2.80
Stimulation of the T3-T cell receptor complex induces a membrane-potential-sensitive calcium influx. Cell (1985) 2.69
Identification and quantification of polyphosphoinositides produced in response to platelet-derived growth factor stimulation. Methods Enzymol (1991) 2.69
SRPK2: a differentially expressed SR protein-specific kinase involved in mediating the interaction and localization of pre-mRNA splicing factors in mammalian cells. J Cell Biol (1998) 2.69
Hemangiomas and vascular malformations of infancy and childhood. Pediatr Clin North Am (1993) 2.69
Interleukin 3-dependent survival by the Akt protein kinase. Proc Natl Acad Sci U S A (1997) 2.64
A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell (1994) 2.64
The erbB3 gene product is a receptor for heregulin. J Biol Chem (1994) 2.63
A quorum sensing-associated virulence gene of Pseudomonas aeruginosa encodes a LysR-like transcription regulator with a unique self-regulatory mechanism. Proc Natl Acad Sci U S A (2001) 2.60
CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Nat Genet (1999) 2.60
Phosphoinositide kinases. Biochemistry (1990) 2.56
The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell (2001) 2.53
Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol (2000) 2.50
Vascular tumors and vascular malformations (new issues). Adv Dermatol (1997) 2.48
Association of articular cartilage degradation and loss of boundary-lubricating ability of synovial fluid following injury and inflammatory arthritis. Arthritis Rheum (2005) 2.47
Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts. Mol Cell Biol (1993) 2.47
Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Nat Genet (2001) 2.43
Utilization of oriented peptide libraries to identify substrate motifs selected by ATM. J Biol Chem (2000) 2.42
Sequence requirements for the recognition of tyrosine-based endocytic signals by clathrin AP-2 complexes. EMBO J (1996) 2.42
Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha. Nat Genet (2000) 2.39
The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin. J Biol Chem (2001) 2.37
Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol (1998) 2.36
Phosphatidylinositol (3,4,5)P3 interacts with SH2 domains and modulates PI 3-kinase association with tyrosine-phosphorylated proteins. Cell (1995) 2.34
United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling. Biochem Soc Trans (2003) 2.34
Recognition and specificity in protein tyrosine kinase-mediated signalling. Trends Biochem Sci (1995) 2.31
Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J (1998) 2.29
Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J (1999) 2.28
Vanadate inhibits the red cell (Na+, K+) ATPase from the cytoplasmic side. Nature (1978) 2.27
Interaction of Shc with the zeta chain of the T cell receptor upon T cell activation. Science (1993) 2.25
Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J (2000) 2.24